50
DRUG THERAPY OF ASTHMA DRUG THERAPY OF ASTHMA Glucocorticoids & Anti-Inflammatory Agents Glucocorticoids & Anti-Inflammatory Agents www.freelivedoctor.com www.freelivedoctor.com

Usage of glucocorticoids in bronchial asthma

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Usage of glucocorticoids in bronchial asthma

DRUG THERAPY OF ASTHMADRUG THERAPY OF ASTHMA

Glucocorticoids & Anti-Inflammatory AgentsGlucocorticoids & Anti-Inflammatory Agents

www.freelivedoctor.comwww.freelivedoctor.com

Page 2: Usage of glucocorticoids in bronchial asthma

LEARNING OBJECTIVESLEARNING OBJECTIVES

To understand the mechanism of action of the anti-inflammatory agents used in treating asthma.

To understand the basic physiology of glucocorticoids and the mechanism of action of the glucocorticoid receptor.

To understand the basis for the anti-inflammatory actions of glucocorticoids

To understand the basic mechanisms and pharmacology of glucocorticoid therapy for asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 3: Usage of glucocorticoids in bronchial asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 4: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 1: Asthma is an inflammatory disease and thus effective treatments for the chronic management of asthma should be directed to reduce the inflammatory response

www.freelivedoctor.comwww.freelivedoctor.com

Page 5: Usage of glucocorticoids in bronchial asthma

• Reduce inflammation and immune responsesReduce inflammation and immune responses

• In clinical practice since 1948In clinical practice since 1948

• $10,000,000,000./year market size in US$10,000,000,000./year market size in US

GLUCOCORTICOIDSGLUCOCORTICOIDS

www.freelivedoctor.comwww.freelivedoctor.com

Page 6: Usage of glucocorticoids in bronchial asthma

Steroid Hormones: Derived from CholesterolSteroid Hormones: Derived from CholesterolLipid Soluble: Able Lipid Soluble: Able to cross plasma to cross plasma membrane by membrane by passive diffusionpassive diffusion

www.freelivedoctor.comwww.freelivedoctor.com

Page 7: Usage of glucocorticoids in bronchial asthma

PHYSIOLOGICAL EFFECTS OF GLUCOCORTICOIDS

Regulation of carbohydrate, protein and lipid metabolism Maintenance of fluid and electrolyte balancePreservation of normal function of the cardiovascular system, the immune system, the kidney, skeletal muscle, the endocrine system and the nervous systemPreservation of organismal homeostasis

www.freelivedoctor.comwww.freelivedoctor.com

Page 8: Usage of glucocorticoids in bronchial asthma

GRGR

GRGR

www.freelivedoctor.comwww.freelivedoctor.com

Page 9: Usage of glucocorticoids in bronchial asthma

CELL TYPE FACTOR COMMENTS

Macrophages Prostaglandins, Inhibition of COX-2,Monocytes Leukotrienes Phospholipase A2

IL-1, IL-6. TNF Inhib. Transcript., Release

Endothelial Cells ICAM-1. ELAM-1 Inhib. Transcript., ReleaseIL-1, Prostagl., Leuko. As above

Basophils Histamine, Leukotriene Inhib. IgE Release

Lymphocytes IL-1, IL-2, IL-3, etc As above

Effects of Glucocorticoids on Components of Inflammatory/Immune Responses

www.freelivedoctor.comwww.freelivedoctor.com

Page 10: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 2: The anti-inflammatory and immunosuppressive actions of glucocorticoids play an important role in preventing potential damaging effects of an unopposed inflammatory response and can be exploited therapeutically

www.freelivedoctor.comwww.freelivedoctor.com

Page 11: Usage of glucocorticoids in bronchial asthma

Glucocorticoids: Side EffectsGlucocorticoids: Side Effects

www.freelivedoctor.comwww.freelivedoctor.com

Page 12: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 3: The beneficial effects of systemic glucocorticoids to limit inflammation is counter-balanced by its many adverse side effects

www.freelivedoctor.comwww.freelivedoctor.com

Page 13: Usage of glucocorticoids in bronchial asthma

NUCLEAR RECEPTOR SUPERFAMILYNUCLEAR RECEPTOR SUPERFAMILY

www.freelivedoctor.comwww.freelivedoctor.com

Page 14: Usage of glucocorticoids in bronchial asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 15: Usage of glucocorticoids in bronchial asthma

Glucocorticoid Receptor Regulation of TranscriptionGlucocorticoid Receptor Regulation of Transcription

www.freelivedoctor.comwww.freelivedoctor.com

Page 16: Usage of glucocorticoids in bronchial asthma

Glucocorticoid Response Unit of the PEPCK GeneGlucocorticoid Response Unit of the PEPCK Gene

CEBP/ß TBP

-27-90-325

COUPGR GR

-380

HNF3HNF4

-410-445

+1

Accessory DNA-binding Factors Accessory DNA-binding Factors Required!!Required!!

((Can impart tissue-specificity)Can impart tissue-specificity)

NOTE: Phosphoenolpyruvate carboxykinase (PEPCK) gene NOTE: Phosphoenolpyruvate carboxykinase (PEPCK) gene is glucocorticoid regulated in liver onlyis glucocorticoid regulated in liver onlywww.freelivedoctor.comwww.freelivedoctor.com

Page 17: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 4: Tissue- and cell type-specific effects of glucocorticoids are likely to be driven by many factors that influence the gene regulatory activity of the glucocorticoid receptor

www.freelivedoctor.comwww.freelivedoctor.com

Page 18: Usage of glucocorticoids in bronchial asthma

GRGR +1GRGR

GREGRE Transcriptional ActivationTranscriptional Activation

Transcriptional Repression ITranscriptional Repression I((Direct DNA-bindingDirect DNA-binding))

HH HH

+1

nGREnGRE

GRGRHH

+1

cGREcGRE

GRGRHH

Transcriptional Repression IITranscriptional Repression II((Co-occupancyCo-occupancy))

+1

GRGRHH

NFNFBB

Transcriptional Repression IIITranscriptional Repression III((TetheringTethering))

AP1AP1

Basic Mechanisms of Transcriptional Activation/RepressionBasic Mechanisms of Transcriptional Activation/Repressionby the Glucocorticoid Receptorby the Glucocorticoid Receptor

www.freelivedoctor.comwww.freelivedoctor.com

Page 19: Usage of glucocorticoids in bronchial asthma

Glucocorticoid Side Effects: Molecular Mechanisms

www.freelivedoctor.comwww.freelivedoctor.com

Page 20: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 5: The broad anti-inflammatory actions of glucocorticoids are due primarily to transcriptional repression of many pro-inflammatory genes in multiple cell types by the glucocorticoid receptor.

www.freelivedoctor.comwww.freelivedoctor.com

Page 21: Usage of glucocorticoids in bronchial asthma

From Glass and RosenfeldFrom Glass and Rosenfeldwww.freelivedoctor.comwww.freelivedoctor.com

Page 22: Usage of glucocorticoids in bronchial asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 23: Usage of glucocorticoids in bronchial asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 24: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 6: The glucocorticoid receptor regulates gene transcription (either positively or negatively) through the gene-selective recruitment of histone modifying enzymes

www.freelivedoctor.comwww.freelivedoctor.com

Page 25: Usage of glucocorticoids in bronchial asthma

Glucocorticoid AnalogsGlucocorticoid Analogs

www.freelivedoctor.comwww.freelivedoctor.com

Page 26: Usage of glucocorticoids in bronchial asthma

Relative Potencies of GlucocorticoidsRelative Potencies of Glucocorticoids

Compound Anti-Inflammatory Na+ -Retaining Duration

Potency Potency of Action

Cortisol 1 1 S

Cortisone 0.8 0.8 S

Prednisolone 4 0.8 I

Triamcinolone 5 0 I

Betamethasone 25 0 L

Dexamethasone 25 0 L

S, short (i.e., 8–12 hour biological half-life); I, intermediate (i.e., 12–36 hour biological half-life); L, long (i.e., 36–72 hour biological half-life)

www.freelivedoctor.comwww.freelivedoctor.com

Page 27: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 7: Structural modifications of the natural glucocorticoid cortisol generate hormones with enhanced half-life and more potent and efficacious glucocorticoid activity

www.freelivedoctor.comwww.freelivedoctor.com

Page 28: Usage of glucocorticoids in bronchial asthma

LungTopical effect~2-10%

LiverFirst passMetabolism(inactivation)

GI Tract

MouthDeposition~90% swallowed

LungPulmonary absorption

BLOOD STREAMDrug systemic effect + inactive metabolite

Schematic representation of the disposition of inhaled drugsSchematic representation of the disposition of inhaled drugs

www.freelivedoctor.comwww.freelivedoctor.com

Page 29: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 8: The aerosol delivery of glucocorticoids to the lungs limits systemic exposure to the hormone and greatly reduces side effects

www.freelivedoctor.comwww.freelivedoctor.com

Page 30: Usage of glucocorticoids in bronchial asthma

New Approaches for Glucocorticoid Treatment of Asthma

• Fluticasone propionate (FLONASE)

www.freelivedoctor.comwww.freelivedoctor.com

Page 31: Usage of glucocorticoids in bronchial asthma

New Approaches for Glucocorticoid Treatment of Asthma

fluticasone propionate (FP)

FP-17ß-carboxylic acid derivative

cytochrome P450 3A4(Liver)

1/2000 affinity for GR than FP!!

www.freelivedoctor.comwww.freelivedoctor.com

Page 32: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 9: New generation synthetic glucocorticoids with more rapid metabolism in the liver overcome potential side effects due to ingested hormone upon aerosol delivery

www.freelivedoctor.comwww.freelivedoctor.com

Page 33: Usage of glucocorticoids in bronchial asthma

Dissociated Glucocorticoids: Dissociating Dissociated Glucocorticoids: Dissociating Transactivation from Transrepression Activity Transactivation from Transrepression Activity of the Glucocorticoid Receptorof the Glucocorticoid Receptor

www.freelivedoctor.comwww.freelivedoctor.com

Page 34: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 10: New generation synthetic glucocorticoids that maintain gene repression but limit gene activation by the glucocorticoid receptor (i.e. dissociated glucocorticoids) may hold promise as anti-inflammatory drugs with reduced side effects

www.freelivedoctor.comwww.freelivedoctor.com

Page 35: Usage of glucocorticoids in bronchial asthma

Mechanisms of Glucocorticoid Resistance in AsthmaMechanisms of Glucocorticoid Resistance in Asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 36: Usage of glucocorticoids in bronchial asthma

Increased GRß Expression in Airway T cells of Increased GRß Expression in Airway T cells of Patients with Glucocorticoid-Insensitive AsthmaPatients with Glucocorticoid-Insensitive Asthma

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

From: Hamid QA et al., (1999) Am J Respir Crit Care Med 159, pp. 1600-1604

Bronchoalveolar lavage (BAL) cells and peripheral blood mononuclear cells (PBMC)

www.freelivedoctor.comwww.freelivedoctor.com

Page 37: Usage of glucocorticoids in bronchial asthma

Effects of Stress on GR mRNA Expression in Effects of Stress on GR mRNA Expression in Normal Versus Asthmatic ChildrenNormal Versus Asthmatic Children

QuickTime™ and aTIFF (Uncompressed) decompressor

are needed to see this picture.

GR mRNA analyzed in total RNA samples from lymphocytes

Acute stress in midst of ongoing chronic stress associated with Acute stress in midst of ongoing chronic stress associated with reduced GR mRNA expressionreduced GR mRNA expression

1. Efficiency of GR transcriptional regulation related to GR expression2. Stressful experiences may exacerbate asthma symptoms in children

From: Miller GE & Chen E (2006) Proc Natl Acad Sci USA 103, 5496-5501.www.freelivedoctor.comwww.freelivedoctor.com

Page 38: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 11: Disruptions in GR expression and signal transduction can contribute to corticosteroid-resistant asthma and underlie the worsening effects of stressful events on asthma symptoms.

www.freelivedoctor.comwww.freelivedoctor.com

Page 39: Usage of glucocorticoids in bronchial asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 40: Usage of glucocorticoids in bronchial asthma

Leukotriene Synthesis PathwayLeukotriene Synthesis Pathway

www.freelivedoctor.comwww.freelivedoctor.com

Page 41: Usage of glucocorticoids in bronchial asthma

Leukotriene Synthesis PathwayLeukotriene Synthesis Pathway

www.freelivedoctor.comwww.freelivedoctor.com

Page 42: Usage of glucocorticoids in bronchial asthma

Role of Leukotrienes in the Pathogenesis of AsthmaRole of Leukotrienes in the Pathogenesis of Asthma

www.freelivedoctor.comwww.freelivedoctor.com

Page 43: Usage of glucocorticoids in bronchial asthma

Leukotriene-Modifying Drugs for the Leukotriene-Modifying Drugs for the Treatment of AsthmaTreatment of Asthma

ZYFLO: 5-Lox Inhibitor

SINGULAIR: Leukotriene-receptor antagonist

www.freelivedoctor.comwww.freelivedoctor.com

Page 44: Usage of glucocorticoids in bronchial asthma

Cromolyn SodiumCromolyn Sodium

EFFECTS:• Prevent both early and late asthmatic responses to inhaled allergens such as pollen

•Reduce airway reactivity resulting from exposure to a range of inhaled irritants such as sulfur dioxide and cold air

MECHANISM: Inhibit specific chloride channels in mast MECHANISM: Inhibit specific chloride channels in mast cells and sensory neuronscells and sensory neurons

www.freelivedoctor.comwww.freelivedoctor.com

Page 45: Usage of glucocorticoids in bronchial asthma

Mechanism of Action of Omalizumab (XOLAIR)Mechanism of Action of Omalizumab (XOLAIR)

Omalizumab

www.freelivedoctor.comwww.freelivedoctor.com

Page 46: Usage of glucocorticoids in bronchial asthma

Novel Therapy: Nasal Delivery of an Anti-Novel Therapy: Nasal Delivery of an Anti-inflammatory Peptideinflammatory Peptide

Omalizumab

Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation

Je-Min Choi et al. (2006) Nature Medicine Vol. 12, pp 574-579

www.freelivedoctor.comwww.freelivedoctor.com

Page 47: Usage of glucocorticoids in bronchial asthma

Novel Therapy: Nasal Delivery of an Anti-Novel Therapy: Nasal Delivery of an Anti-inflammatory Peptideinflammatory Peptide

Omalizumab

• CTLA-4 is an activation-induced surface molecule on T cells and is essential for the negative regulation of T-cell activation

• The cytoplasmic domain of CTLA-4 is known to interact with the phosphatases SHP-1 or SHP-2, resulting in dephosphorylation of CD3-TCR chains, ERK and JNK, thereby inhibiting T-cell activation

STRATEGY: DELIVER CYTOPLASMIC STRATEGY: DELIVER CYTOPLASMIC DOMAIN OF CTLA-4 TO AIRWAY CELLS IN DOMAIN OF CTLA-4 TO AIRWAY CELLS IN VIVOVIVO www.freelivedoctor.comwww.freelivedoctor.com

Page 48: Usage of glucocorticoids in bronchial asthma

Novel Therapy: Nasal Delivery of an Anti-Novel Therapy: Nasal Delivery of an Anti-inflammatory Peptideinflammatory Peptide

Omalizumab

STRATEGY: USE PROTEIN TRANSDUCTION STRATEGY: USE PROTEIN TRANSDUCTION DOMAIN!!DOMAIN!!

•Initially identified in Drosophila Antenaepedia protein and HIV Tat protein (1994)•Rich in basic residues•Efficiently enter cells even when linked to heterologous proteins, even when injected systemically

www.freelivedoctor.comwww.freelivedoctor.com

Page 49: Usage of glucocorticoids in bronchial asthma

Novel Therapy: Nasal Delivery of an Anti-Novel Therapy: Nasal Delivery of an Anti-inflammatory Peptideinflammatory Peptide

Omalizumab

Goblet cell staining

Ovalbumin-induced asthma in miceOvalbumin-induced asthma in mice

PTD-linked peptidePTD-linked peptide

www.freelivedoctor.comwww.freelivedoctor.com

Page 50: Usage of glucocorticoids in bronchial asthma

IMPORTANT CONCEPT 12: Anti-inflammatory drugs that act on selective targets may be effective for the treatment of asthma and are likely to have fewer side effects than glucocorticoids

www.freelivedoctor.comwww.freelivedoctor.com